Mackenzie Financial Corp Cytokinetics Inc Transaction History
Mackenzie Financial Corp
- $63.2 Billion
- Q2 2024
A detailed history of Mackenzie Financial Corp transactions in Cytokinetics Inc stock. As of the latest transaction made, Mackenzie Financial Corp holds 6,059 shares of CYTK stock, worth $318,945. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,059
Previous 6,059
-0.0%
Holding current value
$318,945
Previous $424,000
22.64%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding CYTK
# of Institutions
406Shares Held
126MCall Options Held
3.29MPut Options Held
2.01M-
Black Rock Inc. New York, NY14.7MShares$772 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.4MShares$602 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD8.14MShares$428 Million0.28% of portfolio
-
Wellington Management Group LLP Boston, MA7.51MShares$395 Million0.07% of portfolio
-
State Street Corp Boston, MA6.55MShares$345 Million0.02% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $4.96B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...